Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer

Citation
Ht. Depypere et al., Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer, EUR J CANC, 36, 2000, pp. S73-S73
Citations number
1
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
EUROPEAN JOURNAL OF CANCER
ISSN journal
09598049 → ACNP
Volume
36
Year of publication
2000
Supplement
4
Pages
S73 - S73
Database
ISI
SICI code
0959-8049(200009)36:<S73:IOTTBB>2.0.ZU;2-P
Abstract
Tangeretin, a molecule present in citrus fruits and in certain 'natural' me nopausal medications, is an effective tumour growth and invasion inhibitor in vitro of human MCF 7/6 breast cancer cells. However, when added to the d rinking water of MCF 7/6 tumour-bearing mice it neutralises the beneficial tumour-suppressing effect of tamoxifen. Tangeretin reduces the number of na tural killer cells. This may explain why the beneficial suppressive effect of tangeretin on MCF 7/6 cell proliferation in vitro is completely countera cted in vivo. (C) 2000 Elsevier Science Ltd. All rights reserved.